CELCUITY INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2021-04-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-04-08; Total offering amount $5,000,000.
- 2016-02-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-02-11; Total offering amount $3,000,000.
- 2016-02-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-12-04; Total offering amount $5,175,000.
- 2015-12-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-12-04; Total offering amount $5,175,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2021-04-14 | Rule 506(b) | Equity | 2021-04-08 | $5,000,000 | $5,000,000 | $0 | 1 |
| 2016-02-26 | Rule 506(b) | Equity | 2016-02-11 | $3,000,000 | $325,000 | $2,675,000 | 6 |
| 2016-02-26 D/A | Rule 506(b) | Equity | 2015-12-04 | $5,175,000 | $5,175,000 | $0 | 40 |
| 2015-12-18 | Rule 506(b) | Equity | 2015-12-04 | $5,175,000 | $2,150,000 | $3,025,000 | 12 |
| 2014-03-24 | Rule 506(b) | Equity | 2014-02-28 | $4,862,069 | $4,000,000 | $862,069 | 2 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |